Bristol and London, UK, 26 November 2025 - eXmoor Pharma, the integrated cell and gene therapy CDMO with embedded consultancy expertise, and Royal Free London NHS Foundation Trust, through its Cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback